OHSU
Return to Listing

3 result(s) for Liver

PI Name Protocol # Title
Kevin Billingsley IRB00005222 Oregon Liver Tumor Registry
Gina Vaccaro IRB00008019 A Randomized, Double-Blind, Multi-Center Phase 3 Study of ADI-PEG 20 plus Best Supportive Care (BSC) versus Placebo plus BSC in Subjects with Advanced Hepatocellular Carcinoma (HCC) Who Have Failed Prior Systemic Therapy
Willscott Naugler IRB00009526 A randomized, double blind, placebo-controlled, multicenter phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program